Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Return on Sales (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Return on Sales data on record, last reported at 3.4% in Q1 2013.

  • For Q1 2013, Return on Sales fell 306.0% year-over-year to 3.4%; the TTM value through Mar 2013 reached 3.4%, down 282.0%, while the annual FY2012 figure was 0.58%, 769.0% up from the prior year.
  • Return on Sales reached 3.4% in Q1 2013 per SNOA's latest filing, down from 0.09% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.24% in Q1 2011 and bottomed at 10.98% in Q2 2010.
  • Average Return on Sales over 4 years is 2.19%, with a median of 0.36% recorded in 2010.
  • Peak YoY movement for Return on Sales: soared 896bps in 2012, then plummeted -306bps in 2013.
  • A 4-year view of Return on Sales shows it stood at 0.89% in 2010, then rose by 5bps to 0.85% in 2011, then skyrocketed by 110bps to 0.09% in 2012, then crashed by -3999bps to 3.4% in 2013.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 3.4% in Q1 2013, 0.09% in Q4 2012, and 0.18% in Q3 2012.